Hospitalist compensation continues to climb
Hospitalist compensation has continued its steady climb. Read how incentives and bonuses help support hospitalist payouts.
Related Articles
Workplace Culture Trumps Pay for Most Internists: Survey
A survey of internists found workplace culture is prioritized over pay, with physicians emphasizing supportive environments and flexibility in managing job responsibilities.
The Ensign Group adds 9 nursing homes in 2 states
The company said six of the acquired nursing homes were owned by CareTrust REIT and a joint venture investor.
Surgeon catches CANCER from patient in first-of-its-kind case
In an extremely rare case, a doctor operating on a cancer patient in Germany accidentally ‘transplanted’ the disease into himself through an open cut in…
One-step embedding method for maintaining orientation of pathological tissue specimens using agar thin films
Pathological histology examination involves handling a variety of specimens that are cut according to regulations and placed in cassettes. Tissue fragments in the cassettes are…
Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access | NEJM
A new era of long-acting antiretrovirals for HIV treatment and prevention demands a nonlinear approach to global access with faster sharing of technology, decentralized production,…
How does the model minority myth harm Asian American aspirations and health?
Originally posted on Common Sense Family Doctor on March 30, 2022.
FDA Approves Opdivo Qvantig, a Subcutaneous Formulation of Nivolumab
The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.
22 health care predictions for 2025 from medical researchers
Researchers from Mass General Brigham, a health care system in Boston, Massachusetts, shared with Fox News Digital some of the scientific developments and breakthroughs they…
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma | NEJM
The addition of zolbetuximab, an anti–claudin 18.2 antibody, to chemotherapy in gastric and gastroesophageal junction adenocarcinoma led to longer progression-free and overall survival than chemoth…
Year in Review 2024
In the NEJM Journal Watch General Medicine annual review of important clinical research — most of which was summarized in NEJM Journal Watch General
